scispace - formally typeset
W

W. Peter Vandertop

Researcher at University of Amsterdam

Publications -  192
Citations -  8800

W. Peter Vandertop is an academic researcher from University of Amsterdam. The author has contributed to research in topics: Subarachnoid hemorrhage & Glioma. The author has an hindex of 44, co-authored 165 publications receiving 7355 citations. Previous affiliations of W. Peter Vandertop include VU University Medical Center & VU University Amsterdam.

Papers
More filters
Journal ArticleDOI

High grade gliomas

Alexis Leonard, +350 more
- 01 Jun 2012 - 
TL;DR: Methylation of the promoter for the MGMT gene predicts for increased sensitivity to DNA alkylat­ ing agents such as temozolomide and is prognostic for overall survival (OS) in patients with GBM, especially older patients.
Journal ArticleDOI

Preoperative Resectability Estimates of Nonenhancing Glioma by Neurosurgeons and a Resection Probability Map.

TL;DR: Neurosurgeons estimate preoperative resectability before surgery of a nonenhancing glioma rather accurate-with a small bias-and imprecise-with wide limits of agreement, which can be useful for surgical decision-making, planning, and education.
Journal ArticleDOI

Radiosensitivity and TP 53, EGFR amplification and LOH10 analysis of primary glioma cell cultures.

TL;DR: In this small series of early passage glioma cell cultures low radiosensitivity and alterations in cell regulatory genes were seen, and Histopathological classification of glioblastoma multiforme and/or genetic alterations resulted in lower radiosensitivity.
Journal ArticleDOI

Aneurysm detection with computed tomographic angiography in a 1-month-old infant

TL;DR: An infant whose clinical condition deteriorated acutely at 1 month of age because of a subarachnoid hemorrhage with an intracerebellar hematoma and an aneurysm of the left posterior inferior cerebellar artery is reported.
Journal ArticleDOI

A phase I/II study of bevacizumab, irinotecan and erlotinib in children with progressive diffuse intrinsic pontine glioma

TL;DR: In this article, the safety, tolerability, and preliminary efficacy of combined treatment with VEGF inhibitor bevacizumab, topoisomerase I inhibitor irinotecan, and EGFR inhibitor erlotinib in children with progressive diffuse intrinsic pontine glioma (DIPG) were investigated.